Nuformix plc (LON:NFX – Get Free Report)’s stock price dropped 5.9% on Wednesday . The company traded as low as GBX 0.24 and last traded at GBX 0.24. Approximately 6,983,244 shares changed hands during mid-day trading, a decline of 87% from the average daily volume of 54,786,836 shares. The stock had previously closed at GBX 0.26.
Nuformix Stock Down 5.9%
The firm has a market cap of £5.06 million, a P/E ratio of -0.61 and a beta of 1.22. The company has a 50 day moving average of GBX 0.30 and a two-hundred day moving average of GBX 0.17.
Nuformix Company Profile
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Further Reading
- Five stocks we like better than Nuformix
- How to Choose Top Rated Stocks
- Market Momentum: 3 Stocks Poised for Major Breakouts
- Best Stocks Under $5.00
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- 3 Warren Buffett Stocks to Buy Now
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
